Charles River stock looks fairly valued after 95% run
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Charles River Laboratories shares have returned 94.6% over the past year, and a discounted cash flow model puts the current price of $326.29 broadly in line with estimated intrinsic value. The analyst target of $318.87 sits below the $338.54 price, implying 5.8% downside, with ratings at 15 Buy, 2 Hold and 1 Sell. Upside looks limited after the run.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.